LDX 0.00% 4.5¢ lumos diagnostics holdings limited

The re-rate journey, page-261

  1. 1,005 Posts.
    lightbulb Created with Sketch. 200
    Good news is the addressable market was looked at by Lumos in October 2021 based on their Economic Evaluation of FebriDx.

    There is a reason why they managed to raise $63 million 2.5 years ago on IPO.

    Setbacks on FDA approval would no doubt have soured some investors. That is behind us now.

    Bring on agreements and sales!
 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.